Abstract
Historically, autopsies have been a valuable resource for morphologic studies of the human breast, and have been used in conjunction with radiologic evaluation and epidemiology to provide information about population prevalence of pre-malignant and malignant disease. More recently, well-preserved post-mortem breast tissue has also been used to evaluate the status of genes and their expression. Using molecular techniques and immunohistochemistry, quantitation of gene expression and localization of proteins of hormone receptors, growth factor receptors, growth factors, cell-proliferation related antigens and proto-oncogenes can be evaluated in autopsy-derived breast tissue. Expression of the estrogen receptor (ER)3 gene at the mRNA and protein product levels has been evaluate d in breast tissue from infants, children, adolescent girls, and adult women in various phases of the menstrual cycle, pregnancy and post-menopausal. The results of these studies support a role for the ER gene in early as well as pubescent breast development, and also in normal cyclical and abnormal cell proliferation in the terminal-duct-lobular-units (TDLU) of adult women.
Similar content being viewed by others
References
S. A. Bartow, F. A. Mettler, W. C. Black, and M. Moskowitz (1981). Correlations between radiographic patterns and mor-phology of the female breast. Progress in Surg. Pathol. 4:263-275.
T. A. Longacre and S. A. Bartow (1986). A correlative morpho-logic study of human breast and endometrium in the menstrual cycle. Am. J. Surg. Pathol. 10:382-393.
S. A. Bartow, D. R. Pathak, W. C. Black, and C. R. Key (1987). Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60:2751-2760.
S. R. Pollei, F. A. Mettler, S. A. Bartow, G. Moradian, and M. Moskowitz (1987). Prevalence and radiographic detectability of occult breast carcinoma. Radiology 163:459-462.
J. S. Meyer (1977). Cell proliferation in normal breast ducts, fibroadenomas and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age and oral contraceptives. Hum. Pathol. 8:67-81.
D. J. P. Ferguson and T. J. Anderson (1981). Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast. Brit. J. Cancer 4:177-181.
J. O. Drife (1986). Breast development in puberty. Ann. N.Y. Acad. Sci. 464:58-65.
Y. J. Topper and C. S. Freeman (1980). Multiple hormone interactions in the developmental biology of the mammary gland. Physical Rev. 60:1049-1106.
S. R. Wellings (1980). Development of human breast cancer. Adv. Cancer Res. 31:287-314.
M. Tokunaga, C. E. Land, S. Tokuoka, I. Nishimori, M. Sada, and S. Ahiba (1994). Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiant Res. 138:209-223.
S. A. Bartow, W. C. Black, R. W. Waeckerlin, and F. A. Mettler (1982). Fibrocystic disease. A continuing enigma. Pathol. Ann. Part 2 17:93-111.
B. L. Hart, R. T. Steinbock, F. A. Mettler, D. R. Pathak, and S. A. Bartow (1989). Age and race related changes in mammographic parenchymal patterns. Cancer 63:2537-2539.
D. P. Pathak, C. R. Key, S. R. Teaf, M. C. Pike, and S. A. Bartow (1991). Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series. Brit. J. Cancer 63:1005-1009.
S. A. Bartow, D. R. Pathak, F. A. Mettler, C. R. Key, and M. C. Pike (1995). Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am. J. Epidemiol. 142:813-819.
J. C. De La Torre, D. Gonzalez-Dunia, B. Cubitt, M. Mallory, N. Mueller-Lantzsch, F. A. Grasser, L. A. Hansen, and E. Mesliah (1996). Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients. Virology 223:272-282.
M. T. Boyd, R. H. Hildebrandt, and S. A. Bartow (1996). Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res. Treat 37:243-251.
J. M. Chirgwin, A. E. Przybyla, R. J. MacDonald, and W. J. Rutter (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
H. Lehrach, D. Diamond, J.M. Wozney, and J. Boedtker (1977). RNA molecular weight determination by gel electrophoresis under denaturing conditions; a critical re-examination. Biochemistry 16:4743-4751.
J. A. Bonini and C. Hoffmann (1991). A rapid, accurate, nonradioactive method for quantitating RNA on agarose gels. Biotechniques 11:708-709.
R. Correa-Rotter, C. N. Mariash, and M. E. Rosenberg (1992). Loading and transfer control for northern hybridization. Biotechniques 12:154-158.
K. S. Korach (1994). Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527.
J. L. Fendrick, A. M. Raafat, and S. Z. Haslam (1998). Mammary gland growth and development from the postnatal period to postmenopause: Ovarian steroid receptor ontogeny and regulation in the mouse. J. Mam. Gland Biol. Neoplasia 3:7-22.
E. Anderson, R. B. Clarke, and A. Howell (1998). Estrogen responsiveness and control of normal human breast prolifera-tion. J. Mam. Gland Biol. Neoplasia 3:23-35.
D. M. Ignar-Trowbridge, K. G. Nelson, M. C. Bidwell, S. W. Curtis, T. F. Washburn, J. A. McLachlan, and K. S. Korach (1992). Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. USA 89:4658-4662.
S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, P. Chambon (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
O. W. Peterson, P. E. Hoyer, and B. van Deurs (1987). Fre-quency and distribution of estrogen receptor-positive cells in normal, non-lactating human breast tissue. Cancer Res. 47:5748-5751.
C. Markopoulos, U. Berger, P. Wilson, J-C. Gazet, and R. C. Coombes (1988). Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Brit. Med. J. 296:1349-1351.
S. Carpenter, G. Gerogiate, K. S. McCarty, Sr., and K. S. McCarty, Jr. (1989). Immunohistochemical expression of oes-trogen receptor in normal breast tissue. Proc. Royal Soc. Edin-burgh 95B:59-66.
G. H. Smith, R. Sharp, E. C. Kordon, C. Jhappan, and G. Merlino (1995). Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am. J. Pathol. 147:1081-1096.
J. D. Jacquemier, J. Hassoun, M. Torrente, and P. M. Martin (1990). Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages— immunohistochemical study of 107 cases. Breast Cancer Res. Treat 15:109-117.
D. C. Allred, P. O' Connell, S. A. W. Fuqua, and C. K. Osborne (1994). Immunohistochemical studies of early breast cancer evaluation. Breast Cancer Res. Treat. 32:13-18.
N. J. Kenney and R. B. Dickson (1996). Growth factor and sex steroid interactions in breast cancer. J. Mam. Gland Biol. Neoplasia 1:189-198.
J. A. Schroeder and D. C. Lee (1997). Transgenic mice reveal roles for TGFa and EGF receptor in mammary gland development and neoplasia. J. Mam. Gland Biol. Neoplasia 2:119-129.
D. M. Parham and J. Jankowski (1992). Transforming growth factor a in epithelial proliferative disease of the breast. J. Clin. Pathol. 45:513-516.
P. Walter, S. Green, G. Greene, A. Krust, J-M. Barnert, J-M. Jeltsch, A. Staub, E. Jensen, G. Scrace, M. Waterfield, and P. Chambon (1985). Cloning of the human estrogen receptor cDNA. Proc. Natl. Acad. Sci. USA 82:7889-7893.
Rights and permissions
About this article
Cite this article
Bartow, S.A. Use of the Autopsy to Study Ontogeny and Expression of the Estrogen Receptor Gene in Human Breast. J Mammary Gland Biol Neoplasia 3, 37–48 (1998). https://doi.org/10.1023/A:1026641401184
Issue Date:
DOI: https://doi.org/10.1023/A:1026641401184